MarketResearchNest.com adds “Global Hepatitis A Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024”new report to its research database. The report spread across in a 123 pages with table and figures in it.
Pune, India -- (SBWIRE) -- 02/15/2019 -- Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
Scope of the Report:
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.
Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
The worldwide market for Hepatitis A Vaccine is expected to grow at a CAGR of roughly 2.8% over the next five years, will reach 770 million US$ in 2024, from 650 million US$ in 2019.
This report focuses on the Hepatitis A Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Request a sample copy at
https://www.marketresearchnest.com/report/requestsample/535651
Market Segment by Manufacturers, this report covers
- GSK
- Merck
- Sanofi
- Sinovac
- Zhejiang Pukang
- Changchun Institute of Biological
- Kaketsuken
- IMBCA
- ChangSheng
- Convac
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Inactivated Vaccine
- Live Attenuated Vaccine
Market Segment by Applications, can be divided into
- Government Institution
- Private Sector
- Other
Browse full table of contents and data tables at
https://www.marketresearchnest.com/Global-Hepatitis-A-Vaccine-Market-2019-by-Manufacturers-Regions-Type-and-Application-Forecast-to-2024.html
There are 15 Chapters to deeply display the global Hepatitis A Vaccine market.
Chapter 1, to describe Hepatitis A Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hepatitis A Vaccine, with sales, revenue, and price of Hepatitis A Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hepatitis A Vaccine, for each region, from 2013 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2019;
Chapter 12, Hepatitis A Vaccine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
Chapter 13, 14 and 15, to describe Hepatitis A Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.
Order a Purchase Report Copy at
https://www.marketresearchnest.com/report/purchase/535651
About MarketResearchNest.com
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world's most complete and recent database of expert insights on Global industries, organizations, products, and trends.
Contact Us
Mr. Jeet Jain
Sales Manager
sales@marketresearchnest.com
+1-240-284-8070(U.S)
+44-20-3290-4151(U.K)
Connect with us: Google+ | LinkedIn | Twitter | Facebook